BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
3.760
-0.060 (-1.57%)
Mar 31, 2025, 4:00 PM EDT - Market closed

BioAge Labs Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Cash & Equivalents
354.3521.6427.64
Cash & Short-Term Investments
354.3521.6427.64
Cash Growth
1537.17%-21.70%-
Prepaid Expenses
2.750.350.39
Restricted Cash
-3.31-
Total Current Assets
357.125.3128.03
Property, Plant & Equipment
0.790.520.37
Long-Term Investments
0.10.1-
Other Long-Term Assets
0.24-0.03
Total Assets
358.2325.9228.43
Accounts Payable
21.872.26
Accrued Expenses
11.336.553.36
Short-Term Debt
-38.86-
Current Portion of Long-Term Debt
660.17
Current Portion of Leases
0.20.190.05
Current Unearned Revenue
7.833.31-
Other Current Liabilities
0.421.390.02
Total Current Liabilities
27.7858.175.86
Long-Term Debt
2.58.22.25
Long-Term Unearned Revenue
4.67--
Other Long-Term Liabilities
0.160.230.15
Total Liabilities
35.1166.68.27
Additional Paid-In Capital
575.698.145.12
Retained Earnings
-252.81-181.7-117.85
Comprehensive Income & Other
0.250.160.17
Total Common Equity
323.13-173.4-112.56
Shareholders' Equity
323.13-40.6720.16
Total Liabilities & Equity
358.2325.9228.43
Total Debt
8.753.252.47
Net Cash (Debt)
345.65-31.6125.18
Net Cash Per Share
32.22-18.9015.06
Filing Date Shares Outstanding
35.851.671.67
Total Common Shares Outstanding
35.851.671.67
Working Capital
329.33-32.8622.17
Book Value Per Share
9.01-103.62-67.33
Tangible Book Value
323.13-173.4-112.56
Tangible Book Value Per Share
9.01-103.62-67.33
Machinery
0.790.740.58
Construction In Progress
0.18--
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q